|
1
|
Effect of chronic amiodarone therapy on defibrillation energy requirements in humans.
|
J Cardiovasc Electrophysiol
|
2000
|
1.59
|
|
2
|
Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.
|
J Am Coll Cardiol
|
1999
|
1.45
|
|
3
|
Implantation by electrophysiologists of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems.
|
Circulation
|
1994
|
0.90
|
|
4
|
Prevalence of central venous occlusion in patients with chronic defibrillator leads.
|
Am Heart J
|
2001
|
0.85
|
|
5
|
Comparison of implantation of nonthoracotomy defibrillators in the operating room versus the electrophysiology laboratory.
|
Am J Cardiol
|
1995
|
0.83
|
|
6
|
Long-term evaluation of the ventricular defibrillation energy requirement.
|
J Cardiovasc Electrophysiol
|
1998
|
0.79
|
|
7
|
Relation between amiodarone and desethylamiodarone plasma concentrations and ventricular defibrillation energy requirements.
|
Am J Cardiol
|
1997
|
0.79
|
|
8
|
Incidence of lead system malfunction detected during implantable defibrillator generator replacement.
|
Pacing Clin Electrophysiol
|
1996
|
0.76
|
|
9
|
Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death.
|
Am Heart J
|
1995
|
0.75
|